Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography

International Journal of Cardiology

Volumn 162, Issue 3, 2013, Pages 166-171

  Li, Shan ^a   Wang, Yutang ^a   Gai, Luyue ^a   Yang, Tingshu ^a   Liu, Hongbin ^a   Wang, Zhifeng ^a   Bai, Qicai ^a   Xu, Xiuli ^a   Chen, Yundai ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Drug eluting stent; Malapposition; Neointimal coverage; Optical coherence tomography

Indexed keywords

PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSTHESIS FAILURE; STENT THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CROSS-SECTIONAL STUDY; IMPLANTATION; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NEOINTIMAL COVERAGE; OPERATION DURATION; OUTCOME ASSESSMENT; PACLITAXEL ELUTING STENT; PREVALENCE; RIGHT CORONARY ARTERY; SIROLIMUS ELUTING STENT; STENT MALAPPOSITION; STENT STRUT APPOSITION; THROMBUS; ZOTAROLIMUS ELUTING STENT;

AGED; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOINTIMA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84872493652     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.05.076     Document Type: Article

References (30)

1. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxeleluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
2. J.A. Spertus, R. Kettelkamp, C. Vance, C. Decker, P.G. Jones, and J.S. Rumsfeld Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809
3. D.E. Cutlip, D.S. Baim, K.K. Ho, J.J. Popma, A.J. Lansky, and D.J. Cohen Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
4. M. Pfisterer, H.P. Brunner-La Rocca, and P.T. Buser Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents J Am Coll Cardiol 48 2006 2584 2591
5. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
6. P. Urban, A.H. Gershlick, and G. Guagliumi Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry Circulation 113 2006 1434 1441
7. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans. Delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
8. A.V. Finn, M. Joner, and G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441
9. P.F. Davies, J.A. Spaan, and R. Krams Shear stress biology of the endothelium Ann Biomed Eng 33 2005 1714 1718
10. G. Guagliumi, A. Farb, and G. Musumeci Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings Circulation 107 2003 1340 1341
11. M. Takano, M. Yamamoto, and S. Inami Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J Am Coll Cardiol 51 2008 968 969
12. J. Tanigawa, P. Barlis, and K. Dimopoulos The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography Int J Cardiol 134 2009 180 188
13. J. Tanigawa, P. Barlis, and C. Di Mario Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition EuroInterv 3 2007 127 136
14. O.C. Raffel, G.J. Tearney, and D.D. Gauthier Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography Arterioscler Thromb Vasc Biol 27 2007 1820 1827
15. S. Tanimoto, G. Rodriguez-Granillo, and P. Barlis A novel approach for quantitative analysis of intracoronary optical coherence tomography: high inter-observer agreement with computer-assisted contour detection Catheter Cardiovasc Interv 72 2008 228 235
16. M. Takano, S. Inami, and I.K. Jang Evaluation by optical coherence tomography of neointimal coverage of sirolimuseluting stent three months after implantation Am J Cardiol 99 2007 1033 1038
17. D. Matsumoto, J. Shite, and T. Shinke Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 2007 961 967
18. J.S. Kim, I.K. Jang, and C. Fan Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trail IACC Cardiovasc Interv. 2 12 2009 Dec 1240 1247
19. P. Motreff, G. Souteyrand, and S. Levesque Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation Arch Cardiovasc Dis 102 8-9 Aug-Sep 2009 617 624 Epub 2009 Sep 16
20. J.S. Kim, I.K. Jang, and T.H. Kim Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents Heart 95 23 Dec 2009 1907 1912 Epub 2009 Jun 16
21. A. Farb, A.P. Burke, F.D. Kolodgie, and R. Virmani Pathological mechanisms of fatal late coronary stent thrombosis in humans Circulation 108 2003 1701 1706
22. A.D. Levin, N. Vukmirovic, and C.W. Hwang Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel Proc Natl Acad Sci USA 101 2004 9463 9467
23. J.E. Sousa, M.A. Costa, and A. Abizaid Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents Circulation 111 2005 2326 2329
24. A.V. Finn, F.D. Kolodgie, and J. Harnek Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus and paclitaxel eluting stents Circulation 112 2005 270 278
25. S.V. Ranade, K.M. Miller, R.E. Richard, A.K. Chan, M.J. Allen, and M.N. Helmus Physical characterization of controlled release of paclitaxel from the TAXUS Express2 drug-eluting stent J Biomed Mater Res A 71 2004 625 634
26. D.E. Kandzari, M.B. Leon, and J.J. Popma Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial J Am Coll Cardiol 48 2006 2440 2447
27. S. Cook, P. Wenaweser, and M. Togni Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434
28. P.W. Serruys, M. Degertekin, and K. Tanabe Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (randomized study with the sirolimus-eluting velocity balloon expandable stent in the treatment of patients with de novo native coronary artery lesions) trial Circulation 106 2002 798 803
29. G.S. Mintz What to do about late incomplete stent apposition? Circulation 115 2007 2379 2381
30. M. Takano, M. Yamamoto, and Y. Xie Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy Heart 93 2007 1353 1356